Vanguard Group Inc

13F Holdings History for FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Symbol: FATE on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 8.77M shares
Security Ownership: 7.64%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.77M shares of FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE). This represents 7.64% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	7.64%		$9.12M	8.77M			$1.04	13G/A	6/30/2025	29 Jul 2025 13:13:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	+0%	$11.1M	8.8M	+31,727	+0.36%	$1.26	Q3 2025
6/30/2025	0%	0%	$9.82M	8.77M	-1,543,689	-15%	$1.12	Q2 2025
3/31/2025	0%		$8.15M	10.3M	-22,580		$0.79	Q1 2025
12/31/2024	0%	0%	$17M	10.3M	-71,090	-0.68%	$1.65	Q4 2024
9/30/2024	0%	0%	$36.4M	10.4M	-165,691	-1.57%	$3.50	Q3 2024
6/30/2024	0%	+0%	$34.7M	10.6M	+658,807	+6.65%	$3.28	Q2 2024
3/31/2024	0%	+0%	$72.7M	9.91M	+617,644	+6.65%	$7.34	Q1 2024
12/31/2023	0%	0%	$34.8M	9.29M	-1,614,988	-14.8%	$3.74	Q4 2023
9/30/2023	0%	0%	$23.1M	10.9M	-815,023	-6.95%	$2.12	Q3 2023
6/30/2023	0%	+0%	$55.8M	11.7M	+762,427	+6.96%	$4.76	Q2 2023
3/31/2023	0%	+0%	$62.5M	11M	+2,988,396	+37.5%	$5.70	Q1 2023
12/31/2022	0%	+0%	$80.4M	7.97M	+157,571	+2.02%	$10.09	Q4 2022
9/30/2022	0.01%	+0%	$175M	7.81M	+57,040	+0.74%	$22.41	Q3 2022
6/30/2022	0.01%	+0%	$192M	7.76M	+66,768	+0.87%	$24.78	Q2 2022
3/31/2022	0.01%	+0%	$298M	7.69M	+15,385	+0.2%	$38.77	Q1 2022
12/31/2021	0.01%	+0%	$449M	7.68M	+49,441	+0.65%	$58.51	Q4 2021
9/30/2021	0.01%	+0%	$452M	7.63M	+55,665	+0.74%	$59.27	Q3 2021
6/30/2021	0.02%	+0%	$657M	7.57M	+95,144	+1.27%	$86.79	Q2 2021
3/31/2021	0.02%	+0%	$616M	7.48M	+696,950	+10.3%	$82.45	Q1 2021
12/31/2020	0.02%	+0%	$616M	6.78M	+502,525	+8.01%	$90.93	Q4 2020
9/30/2020	0.01%	+0%	$251M	6.28M	+1,177,511	+23.1%	$39.97	Q3 2020
6/30/2020	0.01%	+0%	$175M	5.1M	+1,847,929	+56.8%	$34.31	Q2 2020
3/31/2020	0%	+0%	$72.2M	3.25M	+125,853	+4.03%	$22.21	Q1 2020
12/31/2019	0%	+0%	$61.2M	3.12M	+72,417	+2.37%	$19.57	Q4 2019
9/30/2019	0%	+0%	$47.4M	3.05M	+324,362	+11.9%	$15.53	Q3 2019
6/30/2019	0%	+0%	$55.4M	2.73M	+6,146	+0.23%	$20.30	Q2 2019
3/31/2019	0%	+0%	$47.8M	2.72M	+179,854	+7.08%	$17.57	Q1 2019
12/31/2018	0%	+0%	$32.6M	2.54M	+93,711	+3.83%	$12.83	Q4 2018
9/30/2018	0%	+0%	$39.9M	2.45M	+275,828	+12.7%	$16.29	Q3 2018
6/30/2018	0%	+0%	$24.6M	2.17M	+354,730	+19.5%	$11.34	Q2 2018
3/31/2018	0%	+0%	$17.7M	1.82M	+358,585	+24.6%	$9.76	Q1 2018
12/31/2017	0%	+0%	$8.92M	1.46M	+176,143	+13.7%	$6.11	Q4 2017
9/30/2017	0%	+0%	$5.08M	1.28M	+18,712	+1.48%	$3.96	Q3 2017
6/30/2017	0%	+0%	$4.1M	1.26M	+108,602	+9.4%	$3.24	Q2 2017
3/31/2017	0%	+0%	$5.26M	1.16M	+523,684	+82.9%	$4.55	Q1 2017
12/31/2016	0%	0%	$1.59M	632K	-55,698	-8.1%	$2.51	Q4 2016
9/30/2016	0%	+0%	$2.15M	688K	+30,120	+4.58%	$3.12	Q3 2016
6/30/2016	0%	+0%	$1.12M	658K	+22,098	+3.48%	$1.70	Q2 2016
3/31/2016	0%	+0%	$1.14M	635K	+220,232	+53%	$1.80	Q1 2016
12/31/2015	0%	+0%	$1.4M	415K	+46,264	+12.5%	$3.37	Q4 2015
9/30/2015	0%	+0%	$1.97M	369K	+31,741	+9.41%	$5.33	Q3 2015
6/30/2015	0%	+0%	$2.18M	337K	+156,600	+86.7%	$6.47	Q2 2015
3/31/2015	0%	+0%	$883K	181K	+8,700	+5.06%	$4.89	Q1 2015
12/31/2014	0%		$865K	172K			$5.03	Q4 2014
9/30/2014	0%	+0%	$884K	172K	+23,332	+15.7%	$5.14	Q3 2014
6/30/2014	0%		$938K	149K			$6.31	Q2 2014
3/31/2014	0%	+0%	$1.45M	149K	+130,080	+702%	$9.74	Q1 2014
12/31/2013	0%		$116K	18.5K			$6.26	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.